Experimental analgesic nephropathy.
D000208:Acute Disease; D000277:Adjuvants, Pharmaceutic; D000700:Analgesics / Q000009:adverse effects* / Q000633:toxicity; D000818:Animals; D000890:Anti-Infective Agents; D002908:Chronic Disease; D003681:Dehydration / Q000150:complications; D004285:Dogs; D004338:Drug Combinations; D004340:Drug Contamination; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000276:immunology; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D019966:Substance-Related Disorders / Q000150:complications
D000277:Adjuvants, Pharmaceutic; D000700:Analgesics; D000890:Anti-Infective Agents; D004338:Drug Combinations; D011453:Prostaglandins